Hepatitis C
📧 Sign up to get email alerts when something new happens for Hepatitis C.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-07-11Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin in Adults With Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Genotype 4 Chronic Hepatitis C Virus Infection and Decompensated Cirrhosis [Phase 3]
Phase 3 trial evaluating the safety and efficacy of ombitasvir/paritaprevir/ritonavir with dasabuvir and ribavirin in adults with genotype 1…
-
CLINICAL_TRIALS trial_result · 2017-07-11Clinical Trial Update: Study of Long-term Peg Intron vs. Colchicine in Non-responders. [Phase 4]
Phase 4 clinical trial comparing long-term PegIntron (pegylated interferon alfa-2b) versus Colchicine in hepatitis C patients with advanced …
-
CLINICAL_TRIALS trial_result · 2017-07-07Clinical Trial Update: A Study to Evaluate the Efficacy, Safety and Tolerability of TMC435 in Combination With PegIFN Alfa-2a (Pegasys) and Ribavirin (Copegus) in Treatment-Naïve or Treatment-Experienced, Chronic Hepatitis C Virus Genotype-4 Infected Patients [Phase 3]
Phase 3 trial evaluating TMC435 in combination with PegIFN alfa-2a and ribavirin for treatment-naïve or treatment-experienced chronic hepati…
-
CLINICAL_TRIALS trial_result · 2017-07-07Clinical Trial Update: A First Time in Human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Single and Repeat Doses of GSK2485852 in Chronically Infected Hepatitis C Subjects [Phase 1]
A first-in-human Phase 1 study of GSK2485852 in chronically infected Hepatitis C patients has been terminated. The study assessed safety, to…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: An Open Label Non-Randomized Dose Escalating Trial to Assess Safety and Tolerability of Alb-Interferon Alfa 2b Every Two Weeks With Ribavirin Among HIV/HCV Coinfected Individuals [Phase 1]
Open-label, non-randomized Phase 1 dose-escalation trial evaluating safety and tolerability of Alb-Interferon Alfa 2b given every two weeks …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Transplant-Related Accelerated Progression of Hepatitis C
A completed clinical trial examining transplant-related accelerated progression of hepatitis C in patients with cirrhosis.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Long-Term Therapy With Ribavirin for Chronic Hepatitis C [Phase 4]
Phase 4 clinical trial update noting the completion of long-term ribavirin therapy for chronic hepatitis C.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Genetics of Hepatitis C Virus Infection
A clinical trial update summarizes genetics research related to Hepatitis C virus infection. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2017-06-29Clinical Trial Update: Pilot Study to Assess Efficacy and Safety of Sofosbuvir/Ledipasvir Fixed-dose Combination in Treatment Experienced Subjects With Hepatitis C Virus (HCV) Genotype 1 - HIV Co-infection [Phase 2]
Phase 2 pilot trial assessing the efficacy and safety of the fixed-dose combination sofosbuvir/ledipasvir in treatment-experienced patients …
-
CLINICAL_TRIALS trial_result · 2017-06-29Clinical Trial Update: Study to Assess Efficacy and Safety of Grazoprevir/Elbasvir Associated With Sofosbuvir and Ribavirin in HCV Genotype 1 or 4-infected Patients Who Failed Direct Acting Antivirals (DAA) Bitherapy With Sofosbuvir [Phase 2]
Phase 2 trial evaluating the efficacy and safety of adding Sofosbuvir and Ribavirin to Grazoprevir/Elbasvir in patients with hepatitis C gen…
-
CLINICAL_TRIALS trial_result · 2017-06-28Clinical Trial Update: A First Time in Human Study to Assess GSK2336805 in Healthy Volunteers and Single Doses in Chronically Infected Hepatitis C Patients. [Phase 1]
First-in-human Phase 1 trial of GSK2336805 in healthy volunteers and single-dose administration in chronically infected Hepatitis C patients…
-
CLINICAL_TRIALS trial_result · 2017-06-27Clinical Trial Update: Use-Results Surveillance Study of Sovaldi® Plus Copegus® in Japanese Patients With Chronic Genotype 2 Hepatitis C Virus Infection
This clinical trial update summarizes post-approval surveillance data on the use of sofosbuvir plus ribavirin in Japanese patients with chro…
-
CLINICAL_TRIALS trial_result · 2017-06-23Clinical Trial Update: Direct-acting Antivirals and Hepatocellular Carcinoma Recurrence
A completed clinical trial updates the investigation of whether direct-acting antivirals for hepatitis C influence hepatocellular carcinoma …
-
CLINICAL_TRIALS trial_result · 2017-06-15Clinical Trial Update: The Relationship Between MDSCs and NK Cells Activity of CHC Patient Treated by DAAs [EARLY_Phase 1]
Early-phase 1 trial in patients with chronic hepatitis C examined changes in myeloid-derived suppressor cells and natural killer cell activi…
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: Study to Evaluate the Pharmacokinetics and Safety of GSK2336805 in Subjects With Hepatic Impairment and Healthy Matched Control Subjects [Phase 1]
Phase 1 pharmacokinetics and safety study of GSK2336805 in subjects with hepatic impairment and matched healthy controls has completed.
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: Sonoelastography: Ultrasound Method to Measure Liver Fibrosis [NA]
A completed clinical trial evaluated sonoelastography, an ultrasound method to measure liver fibrosis; results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-06-02Clinical Trial Update: Dose Ranging of GSK2336805 in Combination Therapy [Phase 2]
Phase 2 dose-ranging study of GSK2336805 in combination therapy for chronic hepatitis C was completed, with results posted in June 2017.
-
CLINICAL_TRIALS trial_result · 2017-06-01Clinical Trial Update: Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Adults With Chronic Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV)-1 Coinfection [Phase 3]
Phase 3 trial evaluating the efficacy and safety of sofosbuvir/velpatasvir fixed-dose combination for 12 weeks in adults with chronic HCV an…
-
CLINICAL_TRIALS trial_result · 2017-06-01Clinical Trial Update: Curing HCV in Incarcerated Patients [Phase 4]
Phase 4 clinical trial update investigating cure of hepatitis C in incarcerated individuals; status of the trial is currently unknown.
-
CLINICAL_TRIALS trial_result · 2017-05-25Clinical Trial Update: Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 or 24 Weeks in Genotype 1 or 4 HCV Infected Adults With Sickle Cell Disease [Phase 2]
Phase 2 trial evaluating fixed-dose Ledipasvir/Sofosbuvir for 12 or 24 weeks in adults with Hepatitis C infection and sickle cell disease; r…
-
CLINICAL_TRIALS trial_result · 2017-05-22Clinical Trial Update: Trial of Citalopram for the Prevention of Depression [Phase 3]
Phase 3 trial assessing whether citalopram can prevent depression in individuals with HIV infection or Hepatitis C; the study has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-22Clinical Trial Update: A Study of Combination Treatment With Peginterferon Alfa-2a (Pegasys) Plus Ribavirin (Copegus) in Participants With Chronic Hepatitis C [Phase 4]
A Phase 4 study evaluating the combination of Pegasys (peginterferon alfa-2a) and Copegus (ribavirin) in chronic hepatitis C has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-18Clinical Trial Update: Program of Screening, Prevention and Elimination of Hepatitis C in Penitentiary Institutions in Cantabria (JAILFREE-C) [Phase 4]
A Phase 4 clinical trial program called JAILFREE-C aiming to screen, prevent, and eliminate Hepatitis C in Cantabria's penitentiary institut…
-
CLINICAL_TRIALS trial_result · 2017-05-16Clinical Trial Update: Anti-D for Treating Thrombocytopenia in Adults Infected With Hepatitis C Virus With or Without HIV Co-Infection [Phase 4]
Phase 4 trial evaluating Anti-D (Rho(D) immune globulin) for thrombocytopenia in adults with hepatitis C with or without HIV infection; the …
-
CLINICAL_TRIALS trial_result · 2017-05-15Clinical Trial Update: Ombitasvir/ABT-450/Ritonavir and Dasabuvir Therapy With Low Dose Ribavirin (RBV), Full Dose RBV or RBV Add-On in Treatment Naive Genotype 1a Hepatitis C Virus Infected Adults [Phase 2]
Phase 2 trial assessing Ombitasvir/Paritaprevir/ritonavir plus Dasabuvir with low-dose, full-dose, or add-on ribavirin in treatment-naive ge…